NDC 69278-101 - Dr Cellapy SR Premium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69278-101
- Package NDCs from labels
- 69278-101-01, 69278-101-02
- Manufacturer
- GM Holdings Co., Ltd
- Effective date
- 2020-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dr. Cellapy SR Premium Solution - GM Holdings Co., Ltd | GM Holdings Co., Ltd | 2020-01-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69278-101-01 | Dr Cellapy SR Premium | 5 mL in 1 VIAL | LIQUID | 5 mL | 0.005 in 5mL | 6 |
| 69278-101-02 | Dr Cellapy SR Premium | 5 in 1 BOX | LIQUID | 0.005 in 5mL | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fuligo | CIMICIFUGA, DROSERA, FORMICA RUFA, FULIGO, INULA HEL., KALI MUR, LAPIS ALBUS, SILICEA | BM Private Limited | 3b27225f-4587-d915-e063-6294a90a7225 | 2026-02-12 | Warnings | 660YQ98I10 |
| Aflora | MULTIVITAMIN | Oncora Pharma, LLC | 38e463d1-f608-7cb5-e063-6294a90a4abb | 2026-02-12 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R 6SO6U10H04 P6YC3EG204 |
| Folixia | MULTIVITAMIN | Oncora Pharma, LLC | 413945b5-116b-d8b6-e063-6394a90a55e8 | 2026-02-12 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R 6SO6U10H04 P6YC3EG204 |
| Nutralyn | MULTIVITAMIN | Oncora Pharma, LLC | 33da017b-1e8c-d41c-e063-6394a90aab8c | 2026-02-12 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R 6SO6U10H04 P6YC3EG204 |
| Folaten | MULTIVITAMIN | Oncora Pharma, LLC | 93086235-2c33-424d-b0c3-213031988581 | 2026-02-12 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R 6SO6U10H04 P6YC3EG204 |
| Floravita Mini | FLORAVITA MINI | Florrax Pharmaceutical | 682bda57-21e0-47df-9596-78846d4d97c0 | 2026-02-12 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R P6YC3EG204 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Major Pharmaceuticals | 33ad1eb2-1f05-461c-b01d-82dee4231556 | 2026-02-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | EPSOM SALT | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 1845ea0c-0cb6-482b-abe6-fa17785c5b90 | 2026-02-09 | Warnings | DE08037SAB |
| cyanocobalamin | CYANOCOBALAMIN | Sportpharm LLC | 647842f4-b211-4f52-8b73-975fae767023 | 2026-02-05 | Warnings, Adverse reactions | P6YC3EG204 |
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | MAGNESIUM SULFATE | Sam's West, Inc | 6edb7688-0a64-4a7e-a0c0-9f75c96682fe | 2026-02-03 | Warnings | DE08037SAB |
| TAGOQHIA 5% Minoxidil Hair Growth Sprays Serum | MINOXIDIL | Guangzhou Borderless Technology Co., Ltd. | 49d396bf-f427-7154-e063-6294a90a6043 | 2026-02-02 | Warnings | 6SO6U10H04 |
| TRZSFR 5% Minoxidil Hair Growth Sprays Serum | MINOXIDIL | Guangzhou Borderless Technology Co., Ltd. | 49d40bf8-3ec1-347c-e063-6294a90a7450 | 2026-02-02 | Warnings | 6SO6U10H04 |
| Calcium Chloride | CALCIUM CHLORIDE | Hospira, Inc. | c4c65e48-85f8-4dcf-6281-06e40959cc79 | 2026-02-02 | Warnings, Adverse reactions | M4I0D6VV5M |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Azurity Pharmaceuticals, Inc. | 50f23abd-6a66-44cb-960e-d43c16a5ae5f | 2026-01-31 | Warnings, Adverse reactions | DE08037SAB |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 94ZLA3W45F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.